Mutaflor in other diseases
A prospective post-marketing surveillance study including 3.807 patients revealed the extraordinary width of the empirical-based therapeutic spectrum and actions of E. coli strain Nissle 1917 (Mutaflor).52
Apart from diarrhea and the irritable bowel syndrome, EcN has also been applied in cases of extraintestinal diseases such as neurodermitis or urinary tract infections.
52) Krammer H et al. Probiotische Arzneimitteltherapie mit E. coli Stamm Nissle 1917 (EcN): Ergebnisse einer prospektiven Datenerhebung mit 3807 Patienten. Z Gastroenterol 2006; 44: 651–656.